Company / Assets per Share
Axsome Therapeutics, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$14.17
FY2025
5-year range
$2.33 / $14.17
FY2021-FY2025
Trend
+18.1%
vs FY2024
Sector context
#73 of 210
Health Care
What the data says
At $14.17, Axsome Therapeutics, Inc.'s assets per share ranks #73 of 210 in the Health Care sector. Assets per Share has fluctuated over the past 10 years, ranging from $0.57 in FY2018 to $14.17 in FY2025.
Based on SEC 10-K filings.
14.17 in FY2025 with a 5-year CAGR of +23.2%.
Improved from $13.52 to $14.17 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +17.4%
- 5-Year CAGR
- +23.2%
- 10-Year CAGR
- -
Sector benchmark
#73 of 210 in Health CareTop 35% of 210This company $14.17 Sector average $353.15
▼
-96.0% below sector average
Key checks
Key Insights
- In FY2025, assets per share increased 18.1% year-over-year.
- Ranks #73 out of 210 companies in the Health Care sector.
- Lowest assets per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.17 | +18.1% |
| FY2024 | $12.01 | -11.2% |
| FY2023 | $13.52 | +54.3% |
| FY2022 | $8.77 | +275.6% |
| FY2021 | $2.33 | -53.4% |
| FY2020 | $5.00 | -22.8% |
| FY2019 | $6.48 | +1033.2% |
| FY2018 | $0.57 | -63.4% |
| FY2017 | $1.56 | -21.7% |
| FY2016 | $2.00 | -51.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026